News Cronos continues cash burn with US$161M loss in Q1 With revenue of just US$12.6M in Q1, the Canadian pot firm says it's finally ready to commercialize its synthetic cannabinoids joint venture Jared GnamMay 7, 2021
The weed wire Willow Biosciences to get National Research Council funding Funding will go towards commercialization of rare cannabinoids produced from yeast Michelle GamageSeptember 9, 2020